GW Medical Technologies LLC

GW Medical Technologies' blood test for Alzheimer's is one of the few that doesn't attempt to directly measure amyloid beta. Instead, the company's diagnostic measures CD69 levels on peripheral blood lymphocytes. Two clinical trials of the test, developed at the University of Leipzig, have already been performed and the data suggest the diagnostic is 95% accurate.